¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"test phantom"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • sheep cell agglutination test
    ¾çÇ÷±¸ÀÀÁý°Ë»ç
  • short increment sensitivity index test
    ¹Ì¼¼Áõ°¡°¨¼ö¼ºÁö¼ö°Ë»ç
  • sign test
    ºÎÈ£°ËÁ¤
  • skin-window test
    ÇǺÎâ¹®°Ë»ç
  • urea breath test
    ¿ä¼Ò³¯¼û°Ë»ç, ¿ä¼ÒÈ£±â°Ë»ç
  • venereal disease research laboratory test
    ¸Åµ¶Ç÷û°Ë»ç, VDRL°Ë»ç
  • vestibular function test
    ¾È¶ã±â´É°Ë»ç, ÀüÁ¤±â´É°Ë»ç
  • visual acuity test
    ½Ã·Â°Ë»ç
  • visual acuity test chart
    ½Ã·Â°Ë»çÇ¥
  • Widal test
    À§´Þ°Ë»ç
  • word association test
    ´Ü¾î¿¬»ó°Ë»ç
  • water deprivation test
    ¼öºÐÁ¦ÇѰ˻ç
  • Weil-Felix test
    ¹ÙÀÏ-Æç¸¯½º°Ë»ç
  • Western blot test
    ¿þ½ºÅϺí·Ô°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • intelligence test
    Áö´É°Ë»ç
  • intelligibility test
    ÀÌÇØµµ°Ë»ç
  • intradermal test
    Çdz»°Ë»ç, Çdz»¹ÝÀÀ°Ë»ç
  • intrinsic-plus test
    ³»Àç±Ù¾ç¼º°Ë»ç
  • irresistable impulse test
    ¾ïÁ¦ºÒ´ÉÃæµ¿°Ë»ç
  • Ishihara test plate
    À̽ÃÇ϶ó»ö°¢°Ë»çÇ¥
  • knee bending test
    ¹«¸­±ÁÈû°Ë»ç, ½½°üÀý±¼°î°Ë»ç
  • knee dropping test
    ¹«¸­°üÀý³«Çϰ˻ç, ½½°üÀý³«Çϰ˻ç
  • laboratory test
    °Ë»ç½Ç°Ë»ç
  • lantern test
    »öµî°Ë»ç, ȯµî½ÃÇè
  • latex agglutination test
    ¶óÅØ½ºÀÀÁý½ÃÇè, ¶óÅØ½ºÀÀÁý¹ÝÀÀ°Ë»ç
  • latex fixation test
    ¶óÅØ½º°íÁ¤¹ÝÀÀ°Ë»ç
  • lepromin test
    ·¹ÇÁ·Î¹Î°Ë»ç
  • lethal titer test
    Ä¡»çÁ¤·®°Ë»ç
  • litmus test
    ¸®Æ®¸Ó½º½ÃÇè, ¸®Æ®¸Ó½º°Ë»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • acid elution slide test
    »ê¿ëÃâ½½¶óÀ̵å½ÃÇè
  • acidified serum test
    »ê¼ºÈ­Ç÷û½ÃÇè(ß«àõûùúìôèãËúÐ).
  • acidified serum test
    »ê¼ºÈ­Ç÷û½ÃÇè
  • acoustic reflex(test)
    À½Çâ¹Ý»ç, À̼Ұñ±Ù¹Ý»ç(°Ë»ç)
  • active force generation test
    ±Ù·Â°Ë»ç
  • adsorption test
    ÈíÂø½ÃÇè.
  • adsorption test
    ÈíÂø½ÃÇè, ºÎÂø½ÃÇè
  • afterimage test
    ÀÜ»ó°Ë»ç
  • afterimage transfer test
    ÀÜ»óÀüÀ̰˻ç
  • agar gel precipitin inhibition test
    ÇÑõ°Öħ°­¼Ò ÀúÁö½ÃÇè(¡­ ˽áÈðæò­ãËúÐ).
  • agglutination inhibition test
    ÀÀÁý¾ïÁ¦½ÃÇè(¡­åäð¤ãËúÐ).
  • agglutination test
    ÀÀÁý½ÃÇè.
  • agglutination test
    ÀÀÁý½ÃÇè
  • air test
    °ø±â½ÃÇè.
  • allen test
    ¾Ë·»½ÃÇè
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • coagulase test
    ÄھƱֶóÁ¦½ÃÇè(¡­ãËúÐ).
  • coagulase test
    Ç÷ÀåÀÀ°íÈ¿¼Ò°Ë»ç, ÄھƱֶóÁ¦°Ë»ç
  • coagulation test
    ÀÀ°í½ÃÇè(ëêͳãËúÐ).
  • coccidioidin test
    Ä۽õð¿ÀÀ̵ò½ÃÇè(¡­ãËúÐ).
  • coccidioidin test
    Ä۽õð¿ÀÀ̵ò½ÃÇè(¡­ãËúÐ).
  • cold caloric test
    Çѳð˻ç
  • cold pressor test
    ÇÑ·©Ç÷¾Ð¹ÝÀÀ°Ë»ç
  • cold water test
    ħ¼ö¹ý(öÙâ©Ûö), ³Ã¼ö½ÃÇè.
  • colloidal gold test
    ±³»ó±Ý°Ë»ç(ÎïßÒÐÝËþÞÛ)
  • colloidal gold test
    ±³»ó¿°È­±Ý½ÃÇè.
  • colo(u)rimetric caries susceptibility test
    ¿ì½Ä°¨¼ö¼º ºñ»ö½ÃÇè(ó»ãÝÊïáô àõÝïßäãËúÐ).
  • colony inhibition test
    Áý¶ôÇü¼º ÀúÁö½ÃÇè, ¼¼Æ÷±ºÇü¼º ÀúÁö½ÃÇè
  • color form sorting test
    »öäÇüÅÂ(ßäóôû¡÷¾)Ã߸®±â °Ë»ç(ËþÞÛ)
  • complement consumption test
    º¸Ã¼¼Òºñ½ÃÇè(¡­á¼Þ¨ãËúÐ).
  • complement consumption test
    º¸Ã¼¼Òºñ½ÃÇè(¡­á¼Þ¨ãËúÐ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 13
CFT cardiolipin flocculation test; clinical full time; complement-fixation test
CMT California mastitis test; cancer multistep therapy; catechol methyltransferase; certified medical tr...
CRT cadaveric renal transplant; cardiac resuscitation team; cathode-ray tube; certified; Certified Recor...
CT calcitonin; calf testis; cardiac tamponade; cardiothoracic [ratio]; carotid tracing; carpal tunnel; ...
DAP data acquisition processor; depolarizing afterpotential; diabetes-associated peptide; diaminopimelic...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 13
GCT Glucose Challenge Test
75 g Glucose Tolerance Test
GTT Glucose Tolerance Test
GXT Graded Exercise Test
GEFT Group Embedded Figure Test
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • erythrocyte protoporphyrin test
    ÀûÇ÷±¸ ÇÁ·ÎÅäÆ÷¸£ÇǸ° ½ÃÇè
  • erythrocyte sedimentation test
    ÀûÇ÷±¸ ħ°­ ½ÃÇè
  • esculin hydrolysis test
    ¿¡½ºÄ𸰠°¡¼öºÐÇØ ½ÃÇè
  • esophageal acid infusion test
    ½Äµµ»ê ÁÖÀÔ ½ÃÇè
  • euglobulin lysis test
    À¯±Û·ÎºÒ¸° ¿ëÇØ ½ÃÇè
  • exercise tolerance test
    ¿îµ¿ ºÎÇÏ °Ë»ç
  • exessive diagnositic test
    Áö³ªÄ£ Áø´Ü¹ý
  • exoantigen test
    ¿ÜÇ׿ø ½ÃÇè
  • Fantus test
    ÆÇÅͽº ½ÃÇè
  • Farber's test
    ÆÄÀ̹ö ½ÃÇè
  • Farnworth D-15 test
    ÆÄ¸¥¿ö½º 15»ö»ó °Ë»ç
  • Farr test
    ÆÄ¾Æ¸£ ½ÃÇè
  • femoral nerve stretch test
    ´ëÅð ½Å°æ ½ÅÀü ½ÃÇè
  • fermentation test
    ¹ßÈ¿ ½ÃÇè
  • ferric chloride test
    ¿°È­ Á¦2ö ½ÃÇè
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
pentagastrin test An alternative to histamine for stimulation of acid secretion in gastric analysis.
(05 Mar 2000)
Gofman test A test for various serum lipoproteins that contain cholesterol, as an index of the tendency to the development of atheromatous lesions and arteriosclerosis; the test is based on the differential flotation of molecules of various sizes when the serum is treated in an ultracentrifuge.
(05 Mar 2000)
Meltzer-Lyon test A test used in diagnosis of gallbladder conditions: 25 ml of a 25% solution of magnesium sulfate are delivered into the region of the sphincter of Oddi through a duodenal tube, causing contraction of the gallbladder, relaxation of the sphincter, and the expulsion of bile from the common duct and gallbladder; bile from the common duct is relatively pale and is expelled first, that from the gallbladder follows; samples aspirated from the tube are examined for pus cells, pigment granules, epithelial cells, cholesterol, etc.
(05 Mar 2000)
Goldscheider's test Determination of the temperature sense by touching the skin with a sharp-pointed metallic rod, heated to varying degrees.
(05 Mar 2000)
gold sol test An obsolete, non-specific test for altered proteins in spinal fluid. As originally used by Lange in 1912, the test was thought to be specific for neurosyphilis; however, this proved to be incorrect. Dilutions of spinal fluid are made in saline and to these a colloidal gold solution is added; if altered proteins are present, there is a colour change or precipitate formed. at present, its chief use is to demonstrate cerebrospinal fluid protein abnormalities in multiple sclerosis.
Synonym: gold sol test, Zsigmondy's test.
(05 Mar 2000)
CF test <immunology> Binding of complement as a result of its interaction with immune complexes (the classical pathway) or particular surfaces (alternative pathway).
(18 Nov 1997)
Goodenough draw-alpha-man test A brief test for assessing an individual's level of intelligence based on how accurately drawn and how many elements are included when a child or adult is given a pencil and sheet of white paper and asked to draw a man, the best man he or she is able to draw. Also called the Goodenough draw-alpha-person test and, in its current form, the Goodenough-Harris drawing test.
(05 Mar 2000)
goodness of fit test A statistical test of the hypothesis that data have been randomly sampled or generated from a population that follows a particular theoretical distribution.
(05 Mar 2000)
Reuss' test A test for atropine; the addition of oxidizing agents and sulfuric acid to a liquid containing atropine produces an odour of orange-flowers and roses.
(05 Mar 2000)
performance test A test, such as five of the eleven Wechsler adult intelligence scale subtests, requiring little or no verbal instruction from the examiner and virtually no verbal response by the examinee.
(05 Mar 2000)
Gothlin's test <investigation> A capillary fragility test to determine the presence or absence of scurvy.
(05 Mar 2000)
Rh blocking test A test for nonagglutinating Rh antibodies: an Rh agglutination test is first carried out; if the test for Rh agglutinins is negative, then 1 drop of anti-Rho agglutinating serum of moderate titre is mixed with the patient's serum containing Rh-positive test cells; if after incubating for from 1 to 2 hr at 37°C no agglutination occurs, Rho-blocking antibodies are assumed to be present in the patient's serum.
(05 Mar 2000)
Graham-Cole test Radiography of the gallbladder after ingestion of a contrast medium.
(12 Dec 1998)
chemotherapy drug sensitivity test <investigation> A test to assess a cancerous tissue's response and vulnerability to chemotherapy drugs. This test can help predict a patients response to treatment and suggest which drugs may be useful.
(16 Dec 1997)
Chick-Martin test A method of testing the in vitro efficiency of a bactericidal agent; a standard culture of Salmonella typhi which has been added to a fixed amount of sterilised faeces or yeast is tested for a fixed period (30 minutes), against various concentrations of phenol solution and various concentrations of the disinfectant; the result is expressed as a ratio: the phenol coefficient, which is the highest dilution of the disinfectant under test at which the bacteria are killed, divided by the highest dilution of phenol which sterilises the solution in the same length of time.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 13
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 13
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 13
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 13
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 13
ÅëÇÕ°Ë»ö ¿Ï·á